Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2011
June 2011, Vol 2, No 3
June 2011, Vol 2, No 3
Patients Value Additional Tests for Experimental Cancer Therapies
Value Propositions
,
Value Peer-spectives
June 2011, Vol 2, No 3
A survey of 61 patients with cancer suggests that many patients are willing to undergo extra tests to participate in clinical trials that will give them access to experimental cancer treatments that may offer improved outcomes and potentially increased survival options.
Read Article
New Formulation of Levoleucovorin Approved
FDA Approvals, News & Updates
June 2011, Vol 2, No 3
A new, ready-to-use (RTU) injectable formulation of the folate analog levoleucovorin (Fusilev; Spectrum Pharmaceuticals) received FDA approval.
Read Article
Sunitinib Second New Drug for Pancreatic Neuroendocrine Tumors
FDA Approvals, News & Updates
June 2011, Vol 2, No 3
Sunitinib (Sutent; Pfizer) is the second new option for the treatment of metastasized or unresectable locally advanced progressive pancreatic neuroendocrine cancerous tumors.
Read Article
New Indication for Everolimus for Neuroendocrine Pancreatic Cancer
FDA Approvals, News & Updates
June 2011, Vol 2, No 3
Read Article
FDA Accelerates Abiraterone Approval for Advanced Prostate Cancer
FDA Approvals, News & Updates
June 2011, Vol 2, No 3
Read Article
Vandetanib First Drug Indicated for Medullary Thyroid Cancer
FDA Approvals, News & Updates
June 2011, Vol 2, No 3
The US Food and Drug Administration (FDA) approved the orphan drug vandetanib (trade name pending; AstraZeneca), a tyrosine kinase inhibitor, for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable, locally advanced, or metastatic disease.
Read Article
Dramatic Progress in Fight against Advanced Melanoma
ASCO
,
ASCO Annual Meeting
June 2011, Vol 2, No 3
Chicago, IL—Oncologists do not engage in hyperbole. It is not in their nature. If the word “unprecedented” is used to describe a clinical outcome, it’s because something truly remarkable has occurred; such is the case in the reporting of 2 investigations of advanced melanoma at the 2011 annual meeting of the American Society of Clinical Oncology (ASCO) for the drugs vemurafenib (PLX4032) and ipilimumab (Yervoy).
Read Article
The Challenge of Value-Based Care in Oncology: Improving Clinical Outcomes
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
June 2011, Vol 2, No 3
The focus on value in patient care has taken a prominent place in any discussion related to improving care delivery, but no agreement exists on what that “value” is.
Read Article
Accountable Care Organizations: Implications for Oncologists
By
Rhonda Greenapple, MSPH, Reimbursement Intelligence
Health Policy
,
Policies & Guidelines
June 2011, Vol 2, No 3
The journey for healthcare costsavings is a never-ending process. One of the newest healthcare delivery models, which is mandated for Medicare beneficiaries in the healthcare reform law, is the accountable care organization (ACO).
Read Article
Page 2 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma